Charles J. Dockendorff - 04 Aug 2023 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
Director
Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. Dockendorff
Issuer symbol
HAE
Transactions as of
04 Aug 2023
Transactions value $
$0
Form type
4
Filing time
08 Aug 2023, 16:41:19 UTC
Previous filing
05 May 2023
Next filing
18 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Award +2.23K +21.79% 12.4K 04 Aug 2023 Direct F1, F2
holding HAE Common Stock 17.9K 04 Aug 2023 Spouse?s Revocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.
F2 Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.